Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,992 | 6,959 | 11,477 | 13,072 | 19,734 |
| Depreciation Amortization | 48,096 | 9,789 | 39,702 | 29,416 | 19,849 |
| Income taxes - deferred | -3,224 | 2,108 | -7,133 | -4,462 | -6,485 |
| Accounts receivable | 959 | -5,367 | N/A | N/A | 1,729 |
| Accounts payable and accrued liabilities | -1,860 | -1,459 | 5,204 | 4,131 | 5,813 |
| Other Working Capital | -755 | -13,863 | -43,078 | -24,904 | -13,974 |
| Other Operating Activity | 10,854 | 11,592 | 16,177 | 8,486 | 1,034 |
| Operating Cash Flow | $33,078 | $9,759 | $22,349 | $25,739 | $27,700 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,737 | -2,597 | -9,918 | -11,028 | -7,830 |
| Other Investing Activity | -917 | 0 | -207 | -207 | -207 |
| Investing Cash Flow | $-6,654 | $-2,597 | $-10,125 | $-11,235 | $-8,037 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 9,000 | 4,000 | 17,600 | 1,600 | 1,600 |
| Common Stock Repurchased | 0 | N/A | -27,507 | -27,507 | -27,507 |
| Dividend Paid | -1,376 | -1,376 | -1,749 | -1,258 | -379 |
| Other Financing Activity | -25,291 | -6,265 | -28,947 | -26,891 | -26,791 |
| Financing Cash Flow | $-17,667 | $-3,641 | $-40,603 | $-54,056 | $-53,077 |
| Exchange Rate Effect | 1,511 | 896 | 5,111 | 3,197 | 3,032 |
| Beginning Cash Position | 161,240 | 161,240 | 184,508 | 184,508 | 184,508 |
| End Cash Position | 171,508 | 165,657 | 161,240 | 148,153 | 154,126 |
| Net Cash Flow | $10,268 | $4,417 | $-23,268 | $-36,355 | $-30,382 |
| Free Cash Flow | |||||
| Operating Cash Flow | 33,078 | 9,759 | 22,349 | 25,739 | 27,700 |
| Capital Expenditure | -5,800 | -2,645 | -13,823 | -11,028 | -7,830 |
| Free Cash Flow | 27,278 | 7,114 | 8,526 | 14,711 | 19,870 |